Search results
Jump to navigation
Jump to search
- The chemical reactions and pathways resulting in the formation of cannabinoid.3 statements, 0 sitelinks - 20:49, 7 March 2023
- The series of molecular signals generated as a consequence of a cannabinoid binding to a cell surface receptor. The pathway proceeds with the receptor transmitting the signal to a heterotrimeric G-protein complex and ends with regulation of a downstr3 statements, 0 sitelinks - 20:47, 7 March 2023
- Combining with a cannabinoid to initiate a change in cell activity. Cannabinoids are a class of diverse chemical compounds that include the endocannabinoids and the phytocannabinoids.4 statements, 0 sitelinks - 20:47, 7 March 2023
- class of chemical compounds6 statements, 0 sitelinks - 20:50, 7 March 2023
- ...he [[Australian National Council on Drugs]] concluded cannabis and other [[cannabinoid]]s are contraindicated in pregnancy as they may interact with the endocanna ...matic brain injury|brain trauma]], and [[cystic fibrosis]] (CF) suggesting cannabinoid treatment for [[Child|children]] or [[Young adult|young adults]], in order ...6 KB (774 words) - 20:10, 2 August 2025
- ...he [[Australian National Council on Drugs]] concluded cannabis and other [[cannabinoid]]s are contraindicated in pregnancy as they may interact with the endocanna ...matic brain injury|brain trauma]], and [[cystic fibrosis]] (CF) suggesting cannabinoid treatment for [[Child|children]] or [[Young adult|young adults]], in order ...6 KB (814 words) - 20:09, 2 August 2025
- ...ian National Council on Drugs|オーストラリア薬物国家評議会]]のために作成された報告書では、カンナビスおよびその他の[[cannabinoid/ja|カンナビノイド]]は、内因性カンナビノイド系と相互作用する可能性があるため、妊娠中には禁忌であると結論づけられている。 ...7 KB (155 words) - 14:20, 4 August 2025
- {{for/ja|:en:thermo-chemical conversion temperatures of cannabinoid acids to their orally bioactive form|:en:Comparison_of_phytocannabinoids#De {{Further/ja|Cannabinoid/ja|Cannabis (drug)/ja|Tetrahydrocannabinol/ja|Tetrahydrocannabinolic acid/j ...21 KB (542 words) - 20:56, 8 August 2025
- ...ids#Decarboxylation Conversion Temperatures|decarboxylated cannabinoids]] (cannabinoid acids converted to their orally bioactive form) from [[cannabis extract]] a {{for|thermo-chemical conversion temperatures of cannabinoid acids to their orally bioactive form|Comparison_of_phytocannabinoids#Decarb ...17 KB (2,514 words) - 17:05, 8 August 2025
- * [[Cannabinoid receptor antagonist/ja|カンナビノイド受容体拮抗薬]]が肥満治療のために開発されたのは、カンナビノイド作動薬（[[cannabi |[[Cannabinoid receptor antagonist/ja]] ...22 KB (659 words) - 09:48, 8 March 2024
- ...ids#Decarboxylation Conversion Temperatures|decarboxylated cannabinoids]] (cannabinoid acids converted to their orally bioactive form) from [[cannabis extract]] a {{for|thermo-chemical conversion temperatures of cannabinoid acids to their orally bioactive form|Comparison_of_phytocannabinoids#Decarb ...18 KB (2,594 words) - 17:05, 8 August 2025
- ...ル]] (THC) は大麻の主要な精神作用性成分であり、[[cannabidiol/ja|カンナビジオール]] (CBD) を含む少なくとも65の[[cannabinoid/ja|カンナビノイド]]など、植物中に知られている483の化合物の1つである。大麻は、[[:en:Cannabis smoking|喫煙]]、[[:e ...nition/ja|精神能力]]の低下、慢性的な咳、[[Respiratory tract infection/ja|呼吸器感染症]]への感受性、[[cannabinoid hyperemesis syndrome/ja|カンナビノイド過食症候群]]などがある。 ...76 KB (2,054 words) - 19:53, 7 August 2025
- ...gonist]]s were developed to treat obesity because researchers noticed that cannabinoid agonists (such as [[THC]], the main pharmacologically active component of [ |[[Cannabinoid receptor antagonist]] ...17 KB (2,406 words) - 18:16, 7 March 2024
- ...gonist]]s were developed to treat obesity because researchers noticed that cannabinoid agonists (such as [[THC]], the main pharmacologically active component of [ |[[Cannabinoid receptor antagonist]] ...18 KB (2,460 words) - 18:15, 7 March 2024
- ...one of the 483 known compounds in the plant, including at least 65 other [[cannabinoid]]s, such as [[cannabidiol]] (CBD). Cannabis can be used [[Cannabis smoking| ...ptibility to [[Respiratory tract infection|respiratory infections]], and [[cannabinoid hyperemesis syndrome]]. ...62 KB (9,106 words) - 14:25, 4 August 2025
- ...one of the 483 known compounds in the plant, including at least 65 other [[cannabinoid]]s, such as [[cannabidiol]] (CBD). Cannabis can be used [[Cannabis smoking| ...ptibility to [[Respiratory tract infection|respiratory infections]], and [[cannabinoid hyperemesis syndrome]]. ...64 KB (9,394 words) - 14:24, 4 August 2025
- ...ル[[Acyl carrier protein/ja|ACP]]誘導体、脂肪酸カルニチンなどの重要な生化学的中間体が含まれる。脂肪アミドとしては、[[cannabinoid/ja|カンナビノイド]]神経伝達物質[[anandamide/ja|アナンダミド]]などの[[N-acylethanolamine/ja|N-アシルエ ...42 KB (1,589 words) - 10:44, 25 February 2024
- ...ption/ja|抗侵害受容性]]、[[anxiolytic/ja|抗不安性]]、[[Nervous system/ja|神経原性]]の特性を持つ[[Cannabinoid/ja#Endocannabinoids|エンドカンナビノイド]]の[[Biosynthesis/ja|生合成]]前駆体である。 ...43 KB (2,252 words) - 09:46, 27 February 2024
- ...[[cholinergic/ja|コリン作動薬]]、[[anticholinergic/ja|抗コリン薬]]、[[emetic/ja|催吐薬]]、[[cannabinoid/ja|カンナビノイド]]、[[serotonin antagonist/ja|5-HT（セロトニン）拮抗薬]]などがある。 ...58 KB (1,845 words) - 17:09, 5 November 2023
- ...s, [[anticholinergic|anticholinergic]]s, [[emetic|emetic]]s, [[cannabinoid|cannabinoid]]s, and [[serotonin antagonist|5-HT (serotonin) antagonists]]. ...52 KB (6,923 words) - 17:09, 5 November 2023